These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11956969)

  • 1. Steele-Richardson-Olszewski-syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRI.
    Arnold G; Schwarz J; Tatsch K; Kraft E; Wächter T; Bandmann O; Oertel WH
    J Neural Transm (Vienna); 2002 Apr; 109(4):503-12. PubMed ID: 11956969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G; Tatsch K; Kraft E; Oertel WH; Schwarz J
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI.
    Arnold G; Tatsch K; Oertel WH; Vogl T; Schwarz J; Kraft E; Kirsch CM
    J Neural Transm Suppl; 1994; 42():111-8. PubMed ID: 7964681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.
    van Royen E; Verhoeff NF; Speelman JD; Wolters EC; Kuiper MA; Janssen AG
    Arch Neurol; 1993 May; 50(5):513-6. PubMed ID: 8489409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
    J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography.
    Oyanagi C; Katsumi Y; Hanakawa T; Hayashi T; Thuy Dh; Hashikawa K; Nagahama Y; Fukuyama H; Shibasaki H
    J Neuroimaging; 2002 Oct; 12(4):316-24. PubMed ID: 12380478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography].
    Tranquart F; Le Bras FH; de Toffol B; Autret A; Guilloteau D; Baulieu JL
    Presse Med; 1994 Sep; 23(28):1299-300. PubMed ID: 7984527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Cotard syndrome: (123)I-IBZM SPECT imaging of striatal D(2) receptor binding.
    De Risio S; De Rossi G; Sarchiapone M; Camardese G; Carli V; Cuomo C; Satta MA; Di Giuda D
    Psychiatry Res; 2004 Jan; 130(1):109-12. PubMed ID: 14972373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steele-Richardson-Olszewski syndrome. Progressive supranuclear paresis].
    Sørensen TT
    Ugeskr Laeger; 1991 Dec; 153(49):3469-71. PubMed ID: 1776179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
    Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Zwanzger P; Mulert C; Rupprecht R; Möller HJ; Hegerl U; Padberg F
    J Psychiatr Res; 2006 Jun; 40(4):307-14. PubMed ID: 16259998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
    Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon MH; Bonnet AM; Zilbovicius M; Raynaud C; Agid Y
    J Nucl Med; 1992 Aug; 33(8):1481-5. PubMed ID: 1386104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy.
    Lewerenz J; Zurowski B; Jenicke L; Bäumer T; Lees AJ; Münchau A
    Mov Disord; 2005 Aug; 20(8):1071-5. PubMed ID: 15838851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical and subcortical patterns of I-123 iodobenzamide SPECT in striatal D(2) receptor parkinsonisms.
    Pifarré P; Cuberas G; Hernández J; Lorenzo C; Miquel F; Castell-Conesa J
    Clin Nucl Med; 2010 Apr; 35(4):228-33. PubMed ID: 20305408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between striatal dopamine D2/D3 receptor availability and verbal intelligence quotient in healthy volunteers.
    Guo JF; Kuang Yang Y; Tsing Chiu N; Lieh Yeh T; See Chen P; Lee IH; Lin Chu C
    Psychol Med; 2006 Apr; 36(4):547-54. PubMed ID: 16359604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Steele-Richardson-Olszewski syndrome].
    Mano Y
    Nihon Rinsho; 1993 Nov; 51(11):2962-7. PubMed ID: 7903988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity.
    van de Giessen E; Celik F; Schweitzer DH; van den Brink W; Booij J
    J Psychopharmacol; 2014 Sep; 28(9):866-73. PubMed ID: 24785761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptor imaging and measurement with SPECT.
    Brücke T; Wenger S; Asenbaum S; Fertl E; Pfafflmeyer N; Müller C; Podreka I; Angelberger P
    Adv Neurol; 1993; 60():494-500. PubMed ID: 8420177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
    Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
    J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.